Albillos SM, Montero O, Calvo S et al (2021) Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson’s disease and essential tremor. A case control biomarker study. Parkinsonism Relat Disord 91:167–172. https://doi.org/10.1016/j.parkreldis.2021.09.014

Article  CAS  PubMed  Google Scholar 

Bourebaba N, Ngo T, Śmieszek A et al (2022) Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment. Biomed Pharmacother 153:113261. https://doi.org/10.1016/j.biopha.2022.113261

Article  CAS  PubMed  Google Scholar 

Bovenzi R, Sancesario GM, Conti M et al (2023) Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study. Eur J Neurol 30:1983–1990. https://doi.org/10.1111/ene.15801

Article  PubMed  Google Scholar 

Bowden J, Holmes MV (2019) Meta-analysis and Mendelian randomization: a review. Res Synth Methods 10:486–496. https://doi.org/10.1002/jrsm.1346

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40:304–314. https://doi.org/10.1002/gepi.21965

Article  PubMed  PubMed Central  Google Scholar 

Brissenden JA, Scerbak T, Albin RL, Lee TG (2024) Motivational vigor in Parkinson’s disease requires the short and long duration response to levodopa. Mov Disord 39:76–84. https://doi.org/10.1002/mds.29659

Article  PubMed  Google Scholar 

Burgess S, Thompson SG (2011) Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med 30:1312–1323. https://doi.org/10.1002/sim.4197

Article  PubMed  Google Scholar 

Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377–389. https://doi.org/10.1007/s10654-017-0255-x

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Thompson SG, Genetics Collaboration CRPCHD (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40:755–764. https://doi.org/10.1093/ije/dyr036

Article  PubMed  Google Scholar 

Chen X, Hu Y, Cao Z et al (2018) Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol 9:2122. https://doi.org/10.3389/fimmu.2018.02122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chew G, Mai AS, Ouyang JF et al (2024) Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease. NPJ Parkinsons Dis 10:99. https://doi.org/10.1038/s41531-024-00698-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Lope EG, Loo RTJ, Rauschenberger A et al (2024) Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism. NPJ Parkinsons Dis 10:68. https://doi.org/10.1038/s41531-024-00671-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng X, Saffari SE, Ng SYE et al (2022) Blood lipid biomarkers in early Parkinson’s disease and Parkinson’s disease with mild cognitive impairment. J Parkinsons Dis 12:1937–1943. https://doi.org/10.3233/JPD-213135

Article  CAS  PubMed  Google Scholar 

Evans DM, Zhu G, Dy V et al (2013) Genome-wide association study identifies loci affecting blood copper, selenium and zinc. Hum Mol Genet 22:3998–4006. https://doi.org/10.1093/hmg/ddt239

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao M, Zhang C, Gao L et al (2023) Association between C-reactive protein-albumin ratio and overall survival in Parkinson’s disease using publicly available data: a retrospective cohort study. Heliyon 9:e12671. https://doi.org/10.1016/j.heliyon.2022.e12671

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glaab E, Trezzi J-P, Greuel A et al (2019) Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson’s disease. Neurobiol Dis 124:555–562. https://doi.org/10.1016/j.nbd.2019.01.003

Article  CAS  PubMed  Google Scholar 

Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408. https://doi.org/10.7554/eLife.34408

Article  PubMed  PubMed Central  Google Scholar 

Hinkle JT, Mills KA, Morrow CB, Pontone GM (2024) Anxiety change after dopamine therapy in Parkinson disease is independent of motor improvement. Am J Geriatr Psychiatry 32:220–229. https://doi.org/10.1016/j.jagp.2023.09.001

Article  PubMed  Google Scholar 

Imbalzano G, Artusi CA, Ledda C et al (2024) Effects of continuous dopaminergic stimulation on Parkinson’s disease gait: a longitudinal prospective study with levodopa intestinal gel infusion. J Parkinsons Dis. https://doi.org/10.3233/JPD-240003

Article  PubMed  PubMed Central  Google Scholar 

Jagdish RK, Maras JS, Sarin SK (2021) Albumin in advanced liver diseases: the good and bad of a drug! Hepatology 74:2848–2862. https://doi.org/10.1002/hep.31836

Article  CAS  PubMed  Google Scholar 

Lawrence AD, Evans AH, Lees AJ (2003) Compulsive use of dopamine replacement therapy in Parkinson’s disease: reward systems gone awry? Lancet Neurol 2:595–604. https://doi.org/10.1016/s1474-4422(03)00529-5

Article  CAS  PubMed  Google Scholar 

Li J, Zhu H, Li J et al (2023) A wearable multi-segment upper limb tremor assessment system for differential diagnosis of Parkinson’s disease versus essential tremor. IEEE Trans Neural Syst Rehabil Eng 31:3397–3406. https://doi.org/10.1109/TNSRE.2023.3306203

Article  PubMed  Google Scholar 

Llorens F, Schmitz M, Gloeckner SF et al (2015) Increased albumin CSF/serum ratio in dementia with Lewy bodies. J Neurol Sci 358:398–403. https://doi.org/10.1016/j.jns.2015.10.011

Article  CAS  PubMed  Google Scholar 

Lotankar S, Prabhavalkar KS, Bhatt LK (2017) Biomarkers for Parkinson’s disease: recent advancement. Neurosci Bull 33:585–597. https://doi.org/10.1007/s12264-017-0183-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manoutcharian K, Gevorkian G (2024) Recombinant antibody fragments for immunotherapy of Parkinson’s disease. BioDrugs 38:249–257. https://doi.org/10.1007/s40259-024-00646-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez Pomier K, Ahmed R, Huang J, Melacini G (2024) Inhibition of toxic metal-alpha synuclein interactions by human serum albumin. Chem Sci 15:3502–3515. https://doi.org/10.1039/d3sc06285f

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamori M, Toko M, Yamada H et al (2024) Association between motor symptoms of Parkinson’s disease and swallowing disorders. Neurol Sci 45:2021–2026. https://doi.org/10.1007/s10072-023-07238-1

Article  PubMed  Google Scholar 

Narinx N, David K, Walravens J et al (2022) Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. Cell Mol Life Sci 79:543. https://doi.org/10.1007/s00018-022-04562-1

Article  CAS  PubMed  Google Scholar